Oral cancer screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(18 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Oral cancer}}
{{Oral cancer}}
{{CMG}}{{AE}}{{Simrat}}
{{CMG}}; {{AE}} {{SSW}}; {{GRR}} {{Nat}}
==Overview==
==Overview==
There is insufficient evidence to recommend routine screening for oral cancer.
There is insufficient evidence to recommend routine [[screening]] for oral cancer.
 
==Screening==
==Screening==
The goal of oral cancer screening is to detect mouth cancer or precancerous lesions that may lead to mouth cancer but no studies have proved that oral cancer screening saves lives, so not all organizations agree about the benefits of an oral exam for oral cancer screening. Some groups recommend screening, while others don't. People with a high risk of oral cancer may be more likely to benefit from oral cancer screening, though studies haven't clearly proved that.  
* There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for oral cancer.<ref name="SpeightEpstein2017">{{cite journal|last1=Speight|first1=Paul M.|last2=Epstein|first2=Joel|last3=Kujan|first3=Omar|last4=Lingen|first4=Mark W.|last5=Nagao|first5=Toru|last6=Ranganathan|first6=Kannan|last7=Vargas|first7=Pablo|title=Screening for oral cancer—a perspective from the Global Oral Cancer Forum|journal=Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|volume=123|issue=6|year=2017|pages=680–687|issn=22124403|doi=10.1016/j.oooo.2016.08.021}}</ref>
===There is no standard or routine screening test for oral cancer===
* There is no country that has any routine [[Screening (medicine)|screening]] program for oral cancer.  
Screening for oral cancer may be done during a routine check-up by a dentist or medical doctor. The exam will include looking for lesions, including areas of leukoplakia (an abnormal white patch of cells) and erythroplakia (an abnormal red patch of cells). Leukoplakia and erythroplakia lesions on the mucous membranes may become cancerous.
* There is insufficient evidence to support any [[Screening (medicine)|screening]] modality that might decrease mortality in oral cancer.  
If lesions are seen in the mouth, the following procedures may be used to find abnormal tissue that might develop into oral cancer:
 
*Toluidine blue stain: A procedure in which lesions in the mouth are coated with a blue dye. Areas that stain darker are more likely to be cancer or become cancer.
Fluorescence staining: A procedure in which lesions in the mouth are viewed using a special light. After the patient uses a fluorescent mouth rinse, normal tissue looks different from abnormal tissue when seen under the light.
*Exfoliative cytology: A procedure to collect cells from the lip or oral cavity. A piece of cotton, a brush, or a small wooden stick is used to gently scrape cells from the lips, tongue, mouth, or throat. The cells are viewed under a microscope to find out if they are abnormal.
*Brush biopsy: The removal of cells using a brush that is designed to collect cells from all layers of a lesion. The cells are viewed under a microscope to find out if they are abnormal.
More than half of oral cancers have already spread to lymph nodes or other areas by the time they are found. No studies have shown that screening would decrease the risk of dying from this disease.
 
===Risks of Oral Cavity and Oropharyngeal Cancer Screening===
*Screening tests have risks.
*The risks of oral cancer screening include the following:
**Finding oral cancer may not improve health or help a person live longer.
**False-negative test results can occur.
**False-positive test results can occur.
**Misdiagnosis can occur.


==References==
==References==
Line 33: Line 17:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Mature chapter]]
[[Category:Mature chapter]]
[[Category:Needs content]]
 


{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Otolaryngology]]
[[Category:Gastroenterology]]
[[Category:Surgery]]

Latest revision as of 12:50, 11 April 2019

Oral cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oral cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oral cancer screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oral cancer screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oral cancer screening

CDC on Oral cancer screening

Oral cancer screening in the news

Blogs on Oral cancer screening

Directions to Hospitals Treating Oral cancer

Risk calculators and risk factors for Oral cancer screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]

Overview

There is insufficient evidence to recommend routine screening for oral cancer.

Screening

  • There is insufficient evidence to recommend routine screening for oral cancer.[1]
  • There is no country that has any routine screening program for oral cancer.
  • There is insufficient evidence to support any screening modality that might decrease mortality in oral cancer.

References

  1. Speight, Paul M.; Epstein, Joel; Kujan, Omar; Lingen, Mark W.; Nagao, Toru; Ranganathan, Kannan; Vargas, Pablo (2017). "Screening for oral cancer—a perspective from the Global Oral Cancer Forum". Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 123 (6): 680–687. doi:10.1016/j.oooo.2016.08.021. ISSN 2212-4403.


Template:WH Template:WS